4.2 Article

Home Mechanical Ventilation for COPD: High-Intensity Versus Target Volume Noninvasive Ventilation

期刊

RESPIRATORY CARE
卷 59, 期 9, 页码 1389-1397

出版社

DAEDALUS ENTERPRISES INC
DOI: 10.4187/respcare.02941

关键词

Chronic obstructive pulmonary disease; mechanical ventilation; sleep quality; target volume; ventilation mode

资金

  1. Breas Medical
  2. Respironics
  3. ResMed Germany
  4. Weinmann
  5. Vivisol
  6. Heinen und Lowenstein
  7. Werner und Muller Medizintechnik
  8. SenTec AG
  9. Radiometer Medical Aps
  10. Keller Medical
  11. SenTec
  12. Vivisol Germany
  13. Sapio Life
  14. Bayer
  15. VitalAire
  16. ResMed
  17. Drager Medical
  18. Linde
  19. Covidien
  20. Magnet
  21. Siare

向作者/读者索取更多资源

BACKGROUND: High-intensity noninvasive ventilation (HI-NIV) is the most effective means of improving several physiological and clinical parameters in subjects with chronic hypercapnic COPD. Whether the newer hybrid mode using target tidal volume noninvasive ventilation (target V-T NIV) provides additional benefits remains unclear. METHODS: Subjects with COPD successfully established on long-term HI-NIV were switched to target V-T NW. Optimal target V-T settings according to nocturnal transcutaneous P-CO2 measurements were achieved following a randomized crossover trial using 8 mL/kg ideal body weight and 110% of individual V-T during HI-MV, respectively. The following parameters were compared at the beginning of the trial while subjects were on HI-NW, and after 3 months on optimal target V-T NIV: sleep quality by polysomnography, overnight gas exchange, subjects' tolerance, overnight pneumotachygraphic measurements during NW, health-related quality of life (severe respiratory insufficiency questionnaire), exercise capacity (6-min walk test), and lung function. RESULTS: Ten of 14 subjects completed the study. There were no differences between HI-NIV and target V-T NIV in any of the above-mentioned parameters. Specifically, the mean overnight transcutaneous P-CO2, was equivalent under each form of ventilation (both 45 +/- 5 mm Hg, P = .75). CONCLUSIONS: Switching subjects from well-established HI-NIV to target V-T NIV shows no clinical benefits in chronic hypercapnic COPD. In particular, sleep quality, the control of nocturnal hypoventilation, daytime hypercapnia, overnight ventilation patterns, subjects' tolerance, health-related quality of life, lung function, and exercise capability were all similar in subjects who underwent HI-NIV and target V-T NW. Nevertheless, target V-T NW might offer some physiological advantages in breathing pattern and might be beneficial in some individual patients. (German Clinical Trials Register Iwww.drks.dej Registration DRKS00000450.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据